• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用氯贝丁酯(乙基-α-(对氯苯氧基异丁酸酯))处理的小鼠肝脏中的环氧化物代谢,氯贝丁酯是一种过氧化物酶体增殖剂。

Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator.

作者信息

Moody D E, Loury D N, Hammock B D

出版信息

Toxicol Appl Pharmacol. 1985 May;78(3):351-62. doi: 10.1016/0041-008x(85)90240-6.

DOI:10.1016/0041-008x(85)90240-6
PMID:4049385
Abstract

An increase in cytosolic epoxide hydrolase (cEH) activity occurs in the livers of mice treated with peroxisome proliferating-hypolipidemic-nongenotoxic carcinogens. As increases in activity of epoxide metabolizing enzymes may reflect the carcinogenic mechanism, a detailed comparison of the response of cEH, microsomal epoxide hydrolase (mEH), and cytosolic glutathione S-transferase (cGST) activities using the geometrical isomers trans- and cis-stilbene oxide as substrates has been performed in livers from mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate]. The maximal increase of cEH activity occurred at lower dietary doses of clofibrate (0.5%) and within a shorter time (5 days) than mEH and cGST (2%, 14 days) activity. After 14 days at 0.5% clofibrate, cEH, mEH, and cGST activities were 250, 175, and 165% and 290, 220, and 75% of control values in male and female mice, respectively. Withdrawal of clofibrate from the diet resulted in a reversion of activities to control values within 7 days. Clofibrate treatment shifted the apparent subcellular compartmentation of all three enzymatic activities with an increase in the ratio of soluble to particulate activity. In particular, the relative specific activity of all three enzymes decreased in the light mitochondrial (peroxisomal) cell fraction, and an increase of a mEH-like activity (benzo[a]pyrene-4,5-oxide and cis-stilbene oxide hydrolysis) in the cytosol occurred. Both the increase of cEH activity and the appearance of mEH-like activity in the cytosol are novel responses of epoxide metabolizing enzymes, which may be related to the novel cellular responses that follow clofibrate treatment, peroxisome proliferation, hypolipidemia, and nongenotoxic carcinogenesis.

摘要

用过氧化物酶体增殖性降血脂非基因毒性致癌物处理的小鼠肝脏中,胞质环氧化物水解酶(cEH)活性会增加。由于环氧化物代谢酶活性的增加可能反映致癌机制,因此已使用反式和顺式氧化芪这两种几何异构体作为底物,对用氯贝丁酯(乙基-α-(对氯苯氧基异丁酸酯))处理的小鼠肝脏中cEH、微粒体环氧化物水解酶(mEH)和胞质谷胱甘肽S-转移酶(cGST)活性的反应进行了详细比较。cEH活性的最大增加出现在氯贝丁酯饮食剂量较低(0.5%)时,且比mEH和cGST活性(2%,14天)出现的时间更短(5天)。在0.5%氯贝丁酯处理14天后,雄性和雌性小鼠的cEH、mEH和cGST活性分别为对照值的250%、175%和165%以及290%、220%和75%。从饮食中撤去氯贝丁酯后,活性在7天内恢复到对照值。氯贝丁酯处理改变了所有三种酶活性的表观亚细胞区室化,可溶性与颗粒性活性的比值增加。特别是,所有三种酶的相对比活性在轻线粒体(过氧化物酶体)细胞组分中降低,而胞质中出现了类似mEH的活性(苯并[a]芘-4,5-氧化物和顺式氧化芪水解)。cEH活性的增加以及胞质中类似mEH活性的出现都是环氧化物代谢酶的新反应,这可能与氯贝丁酯处理、过氧化物酶体增殖、降血脂和非基因毒性致癌作用后的新细胞反应有关。

相似文献

1
Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator.用氯贝丁酯(乙基-α-(对氯苯氧基异丁酸酯))处理的小鼠肝脏中的环氧化物代谢,氯贝丁酯是一种过氧化物酶体增殖剂。
Toxicol Appl Pharmacol. 1985 May;78(3):351-62. doi: 10.1016/0041-008x(85)90240-6.
2
Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes.环境中接触到的环氧化物对小鼠肝脏环氧化物代谢酶的影响。
Biochem Pharmacol. 1991 Jun 1;41(11):1625-37. doi: 10.1016/0006-2952(91)90163-y.
3
Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice.饮食中氯贝丁酯对小鼠组织中环氧化物水解酶活性的影响。
Biochem Pharmacol. 1985 May 15;34(10):1827-33. doi: 10.1016/0006-2952(85)90656-2.
4
Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities.胞质环氧化物水解酶、微粒体环氧化物水解酶和谷胱甘肽S-转移酶活性的差异诱导。
Toxicol Appl Pharmacol. 1983 Nov;71(2):254-65. doi: 10.1016/0041-008x(83)90342-3.
5
Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate.
Xenobiotica. 1989 Aug;19(8):867-81. doi: 10.3109/00498258909043147.
6
Microsomal and cytosolic epoxide hydrolase and glutathione S-transferase activities in the gill, liver, and kidney of the rainbow trout, Salmo gairdneri. Baseline levels and optimization of assay conditions.
Biochem Pharmacol. 1989 Mar 15;38(6):881-7. doi: 10.1016/0006-2952(89)90275-x.
7
Hepatic epoxide hydrolase activities and their induction by clofibrate and diethylhexylphthalate in various strains of mice.不同品系小鼠肝脏环氧水解酶活性及其受氯贝丁酯和邻苯二甲酸二(2-乙基己基)酯诱导的情况。
Biochem Pharmacol. 1987 Dec 15;36(24):4221-7. doi: 10.1016/0006-2952(87)90662-9.
8
Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats.雄性斯普拉格-道利大鼠胞质环氧化物水解酶的分布及诱导性
Biochem Pharmacol. 1986 Oct 1;35(19):3309-16. doi: 10.1016/0006-2952(86)90428-4.
9
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.降血脂化合物对月桂酸羟基化及Ⅱ相酶的影响。
Biochem Pharmacol. 1989 Jun 15;38(12):1963-9. doi: 10.1016/0006-2952(89)90495-4.
10
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.各种降血脂化合物伴随过氧化物酶体β-氧化诱导胞质环氧水解酶而非微粒体环氧水解酶。
Biochem Pharmacol. 1987 Feb 1;36(3):345-51. doi: 10.1016/0006-2952(87)90292-9.

引用本文的文献

1
Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.基于结构的设计与优化促成了一种新型强效可溶性环氧化物水解酶(sEH)抑制剂的发现,该抑制剂具有过氧化物酶体增殖物激活受体γ(PPARγ)部分激动活性,可用于治疗炎症和代谢相关疾病。
J Med Chem. 2025 Apr 24;68(8):8729-8767. doi: 10.1021/acs.jmedchem.5c00402. Epub 2025 Apr 4.
2
PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction.PROTAC 介导的细胞质可溶性环氧化物水解酶的选择性降解增强内质网应激的减轻。
ACS Chem Biol. 2023 Apr 21;18(4):884-896. doi: 10.1021/acschembio.3c00017. Epub 2023 Mar 22.
3
Lipokines and Thermogenesis.
脂联素与产热
Endocrinology. 2019 Oct 1;160(10):2314-2325. doi: 10.1210/en.2019-00337.
4
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.具有可溶性环氧化物水解酶抑制活性的多靶点药物的研发。
Prostaglandins Other Lipid Mediat. 2019 Feb;140:31-39. doi: 10.1016/j.prostaglandins.2018.12.003. Epub 2018 Dec 26.
5
Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.可溶性环氧化物水解酶抑制可减轻阿基塔(Ins2 Akita)小鼠的神经病变。
Behav Brain Res. 2017 May 30;326:69-76. doi: 10.1016/j.bbr.2017.02.048. Epub 2017 Mar 1.
6
Soluble epoxide hydrolase: gene structure, expression and deletion.可溶性环氧化物水解酶:基因结构、表达与缺失。
Gene. 2013 Sep 10;526(2):61-74. doi: 10.1016/j.gene.2013.05.008. Epub 2013 May 20.
7
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.抑制生长激素作用可改善肝脏胰岛素样生长因子-1缺乏小鼠的胰岛素敏感性。
J Clin Invest. 2004 Jan;113(1):96-105. doi: 10.1172/JCI17763.
8
Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.利用cDNA微阵列分析鉴定小鼠肝脏中新型过氧化物酶体增殖物激活受体α(PPARα)靶基因。
Gene Expr. 2001;9(6):291-304. doi: 10.3727/000000001783992533.